tropsium
Jump to navigation
Jump to search
Indications
- used in combination with xanomeline for treatment of schizophrenia
Adverse effects
- peripheral anticholinergic adverse effects
Mechanism of action
- peripheral muscarinic receptor antagonist
- reduces peripheral cholinergic effects of xanomeline
More general terms
Component of
References
- ↑ Brannan SK, Sawchak S, Miller AC et al Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia. N Engl J Med 2021; 384:717-726 Feb 25 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33626254 https://www.nejm.org/doi/full/10.1056/NEJMoa2017015B